Maria Perez-Penco

7PUBLICATIONS
30CO-AUTHORS
Tumour immunologyCancer cell biologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 29, 2025
Arginase-1-specific T cells target and modulate tumor-associated macrophages.

Evelina Martinenaite, Inés Lecoq, Mia Aaboe-Jørgensen

|Feb 28, 2024
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts.

Maria Perez-Penco, Lucia Lara de la Torre, Inés Lecoq

|Jan 05, 2023
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.

Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina

|Oct 31, 2022
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.

Stine Emilie Weis-Banke, Thomas Landkildehus Lisle, Maria Perez-Penco

|Sep 02, 2022
CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment.

Inés Lecoq, Katharina L Kopp, Marion Chapellier

|Feb 03, 2022
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.

Simone Kloch Bendtsen, Maria Perez-Penco, Mie Linder Hübbe

Pageof 2

Frequent Collaborators

7 joint publications

Mads Hald Andersen

2 joint publications

Mia Aaboe Jørgensen

2 joint publications

Marion Chapellier

2 joint publications

Mai-Britt Zocca